P-MAPP: Personalized Medication Adherence and Persistence Program

Launched in September 2019

Focuses on Patients with Type 2 Diabetes

Closing the prescription accountability loop among pharma, pharmacies, prescribers, payers and patients with Type 2 Diabetes